世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

慢性全閉塞デバイス市場(製品タイプ:マイクロカテーテル、ガイドワイヤー、クロッシングデバイス、リエントリーデバイス、その他) - 世界の産業分析、サイズ、シェア、成長、トレンド、および予測、2023-2031年


Chronic Total Occlusion Devices Market (Product Type: Microcatheters, Guidewires, Crossing Devices, Re-entry Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

慢性完全閉塞装置市場 - レポートの範囲 TMRの調査レポート「世界の慢性全閉塞装置市場」は、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Transparency Market Research
トランスペアレンシーマーケットリサーチ
2023年3月3日 US$5,795
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
160 英語

このレポートは受注生産にて作成するため
通常よりご納品にお時間をいただく場合がございます。


 

サマリー

慢性完全閉塞装置市場 - レポートの範囲
TMRの調査レポート「世界の慢性全閉塞装置市場」は、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会も調査しています。本レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの期間における世界の慢性全閉塞デバイス市場の収益を提供します。また、2023年から2031年までの世界の慢性全閉塞デバイス市場の複合年間成長率(CAGR %)を掲載しています。

本レポートは、広範な調査を経て作成されました。一次調査では、主要なオピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施し、調査作業の大部分を行いました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、慢性閉塞性肺疾患市場を把握した。

また、インターネット上の情報源や政府機関、ウェブサイト、業界団体の統計データも二次調査の対象としています。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界の慢性完全閉塞装置市場のさまざまな属性を調査しました。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは、慢性閉塞性肺疾患の世界市場における競争力学の変化に光を当てています。これらは、既存の市場関係者だけでなく、世界の慢性閉塞性肺疾患市場へ参入を検討している企業にとっても貴重なツールになるはずです。

本レポートでは、世界の慢性閉塞性肺疾患市場の競争環境について掘り下げています。世界の慢性閉塞性肺疾患市場で活動する主要企業が特定され、それぞれの企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の慢性閉塞性肺疾患市場のプレイヤーの属性である。

慢性全閉塞装置の世界市場レポートで回答された主な質問
- 予測期間中に全地域で発生した慢性全閉塞デバイスの売上/収益はどの程度か?
- 慢性閉塞性肺疾患の世界市場におけるビジネスチャンスは何か?
- 市場の主な推進要因、阻害要因、機会、脅威は何か?
- 予測期間中に最も速いCAGRで拡大するのはどの地域市場か?
- 2031年に世界で最も高い収益を上げると予測されるセグメントは?
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメントはどこか?
- 世界市場で事業展開している各社の市場ポジションは?

慢性全閉塞装置市場 - 研究目的と研究アプローチ
慢性全閉塞装置の世界市場に関する包括的なレポートは、まず概要から始まり、次に調査範囲と目的について説明しています。本レポートでは、本調査の目的、市場で活動する主要ベンダーと販売業者、製品の承認に関する規制シナリオについて詳しく解説しています。

読みやすさを考慮し、本レポートは章立てでまとめられ、各セクションはより小さなものに分割されています。本レポートは、グラフと表が適切に配置された包括的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えかけています。また、過去と予測期間終了時の主要セグメントの市場シェアを比較することも可能です。

本レポートでは、世界の慢性完全閉塞装置市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントごとの市場シェアを掲載しています。このような貴重な洞察により、市場関係者は、世界の慢性完全閉塞装置市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。

ページTOPに戻る


目次

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chronic Total Occlusion Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Definition
        4.1.2. Industry Evolution /Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Chronic Total Occlusion Devices Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Disease Prevalence & Incidence Rate globally with key countries
    5.2. Technological Advancements
    5.3. Regulatory Scenario by Region/globally
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Microcatheters
        6.3.2. Guidewires
        6.3.3. Crossing Devices
        6.3.4. Re-entry Devices
        6.3.5. Others
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by End-user
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by End-user, 2017–2031
        7.3.1. Hospitals
        7.3.2. Ambulatory Surgical Centers
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by End-user
8. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Market Value Forecast, by Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness Analysis, by Region
9. North America Chronic Total Occlusion Devices Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast, by Product Type, 2017–2031
        9.2.1. Microcatheters
        9.2.2. Guidewires
        9.2.3. Crossing Devices
        9.2.4. Re-entry Devices
        9.2.5. Others
    9.3. Market Value Forecast, by End-user, 2017–2031
        9.3.1. Hospitals
        9.3.2. Ambulatory Surgical Centers
        9.3.3. Others
    9.4. Market Value Forecast, by Country, 2017–2031
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis
        9.5.1. By Product Type
        9.5.2. By End-user
        9.5.3. By Country
10. Europe Chronic Total Occlusion Devices Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2017–2031
        10.2.1. Microcatheters
        10.2.2. Guidewires
        10.2.3. Crossing Devices
        10.2.4. Re-entry Devices
        10.2.5. Others
    10.3. Market Value Forecast, by End-user, 2017–2031
        10.3.1. Hospitals
        10.3.2. Ambulatory Surgical Centers
        10.3.3. Others
    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis
        10.5.1. By Product Type
        10.5.2. By End-user
        10.5.3. By Country/Sub-region
11. Asia Pacific Chronic Total Occlusion Devices Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017–2031
        11.2.1. Microcatheters
        11.2.2. Guidewires
        11.2.3. Crossing Devices
        11.2.4. Re-entry Devices
        11.2.5. Others
    11.3. Market Value Forecast, by End-user, 2017–2031
        11.3.1. Hospitals
        11.3.2. Ambulatory Surgical Centers
        11.3.3. Others
    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis
        11.5.1. By Product Type
        11.5.2. By End-user
        11.5.3. By Country/Sub-region
12. Latin America Chronic Total Occlusion Devices Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Microcatheters
        12.2.2. Guidewires
        12.2.3. Crossing Devices
        12.2.4. Re-entry Devices
        12.2.5. Others
    12.3. Market Value Forecast, by End-user, 2017–2031
        12.3.1. Hospitals
        12.3.2. Ambulatory Surgical Centers
        12.3.3. Others
    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis
        12.5.1. By Product Type
        12.5.2. By End-user
        12.5.3. By Country/Sub-region
13. Middle East & Africa Chronic Total Occlusion Devices Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Microcatheters
        13.2.2. Guidewires
        13.2.3. Crossing Devices
        13.2.4. Re-entry Devices
        13.2.5. Others
    13.3. Market Value Forecast, by End-user, 2017–2031
        13.3.1. Hospitals
        13.3.2. Ambulatory Surgical Centers
        13.3.3. Others
    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis
        13.5.1. By Product Type
        13.5.2. By End-user
        13.5.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player - Competition Matrix (by tier and size of companies)
    14.2. Market Share Analysis, by Company, 2022
    14.3. Company Profiles
        14.3.1. Medtronic
            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.1.2. Product Type Portfolio
            14.3.1.3. Financial Overview
            14.3.1.4. SWOT Analysis
            14.3.1.5. Strategic Overview
        14.3.2. Boston Scientific Corporation
            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.2.2. Product Type Portfolio
            14.3.2.3. Financial Overview
            14.3.2.4. SWOT Analysis
            14.3.2.5. Strategic Overview
        14.3.3. Acrostak Int. Distr. Sàrl
            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.3.2. Product Type Portfolio
            14.3.3.3. Financial Overview
            14.3.3.4. SWOT Analysis
            14.3.3.5. Strategic Overview
        14.3.4. Abbott
            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.4.2. Product Type Portfolio
            14.3.4.3. Financial Overview
            14.3.4.4. SWOT Analysis
            14.3.4.5. Strategic Overview
        14.3.5. Asahi Intecc Co., Ltd.
            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.5.2. Product Type Portfolio
            14.3.5.3. Financial Overview
            14.3.5.4. SWOT Analysis
            14.3.5.5. Strategic Overview
        14.3.6. Cardinal Health
            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.6.2. Product Type Portfolio
            14.3.6.3. Financial Overview
            14.3.6.4. SWOT Analysis
            14.3.6.5. Strategic Overview
        14.3.7. Cook Medical
            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.7.2. Product Type Portfolio
            14.3.7.3. Financial Overview
            14.3.7.4. SWOT Analysis
            14.3.7.5. Strategic Overview
        14.3.8. Merit Medical Systems
            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.8.2. Product Type Portfolio
            14.3.8.3. Financial Overview
            14.3.8.4. SWOT Analysis
            14.3.8.5. Strategic Overview
        14.3.9. MicroPort Scientific Corporation
            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.9.2. Product Type Portfolio
            14.3.9.3. Financial Overview
            14.3.9.4. SWOT Analysis
            14.3.9.5. Strategic Overview
        14.3.10. Penumbra, Inc.
            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.10.2. Product Type Portfolio
            14.3.10.3. Financial Overview
            14.3.10.4. SWOT Analysis
            14.3.10.5. Strategic Overview
        14.3.11. Koninklijke Philips N.V.
            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.11.2. Product Type Portfolio
            14.3.11.3. Financial Overview
            14.3.11.4. SWOT Analysis
            14.3.11.5. Strategic Overview
        14.3.12. Terumo India Private Limited
            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.12.2. Product Type Portfolio
            14.3.12.3. Financial Overview
            14.3.12.4. SWOT Analysis
            14.3.12.5. Strategic Overview
        14.3.13. Teleflex Incorporated
            14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.13.2. Product Type Portfolio
            14.3.13.3. Financial Overview
            14.3.13.4. SWOT Analysis
            14.3.13.5. Strategic Overview
        14.3.14. Becton, Dickinson and Company
            14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.14.2. Product Type Portfolio
            14.3.14.3. Financial Overview
            14.3.14.4. SWOT Analysis
            14.3.14.5. Strategic Overview
        14.3.15. Reflow Medical
            14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.15.2. Product Type Portfolio
            14.3.15.3. Financial Overview
            14.3.15.4. SWOT Analysis
            14.3.15.5. Strategic Overview
        14.3.16. Nitiloop
            14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.16.2. Product Type Portfolio
            14.3.16.3. Financial Overview
            14.3.16.4. SWOT Analysis
            14.3.16.5. Strategic Overview

ページTOPに戻る



図表リスト

List of Tables

Table 01: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 05: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 08: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 11: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 14: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 17: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 18: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

 

ページTOPに戻る


 

Summary

Chronic Total Occlusion Devices Market – Scope of Report
TMR’s report on the global chronic total occlusion devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global chronic total occlusion devices market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global chronic total occlusion devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the chronic total occlusion devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global chronic total occlusion devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global chronic total occlusion devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global chronic total occlusion devices market.

The report delves into the competitive landscape of the global chronic total occlusion devices market. Key players operating in the global chronic total occlusion devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global chronic total occlusion devices market profiled in this report.

Key Questions Answered in Global Chronic Total Occlusion Devices Market Report
• What is the sales/revenue generated by chronic total occlusion devices across all regions during the forecast period?
• What are the opportunities in the global chronic total occlusion devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Chronic Total Occlusion Devices Market – Research Objectives and Research Approach
The comprehensive report on the global chronic total occlusion devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global chronic total occlusion devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global chronic total occlusion devices market.



ページTOPに戻る


Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chronic Total Occlusion Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Definition
        4.1.2. Industry Evolution /Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Chronic Total Occlusion Devices Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Disease Prevalence & Incidence Rate globally with key countries
    5.2. Technological Advancements
    5.3. Regulatory Scenario by Region/globally
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Microcatheters
        6.3.2. Guidewires
        6.3.3. Crossing Devices
        6.3.4. Re-entry Devices
        6.3.5. Others
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by End-user
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by End-user, 2017–2031
        7.3.1. Hospitals
        7.3.2. Ambulatory Surgical Centers
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by End-user
8. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Market Value Forecast, by Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness Analysis, by Region
9. North America Chronic Total Occlusion Devices Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast, by Product Type, 2017–2031
        9.2.1. Microcatheters
        9.2.2. Guidewires
        9.2.3. Crossing Devices
        9.2.4. Re-entry Devices
        9.2.5. Others
    9.3. Market Value Forecast, by End-user, 2017–2031
        9.3.1. Hospitals
        9.3.2. Ambulatory Surgical Centers
        9.3.3. Others
    9.4. Market Value Forecast, by Country, 2017–2031
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis
        9.5.1. By Product Type
        9.5.2. By End-user
        9.5.3. By Country
10. Europe Chronic Total Occlusion Devices Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2017–2031
        10.2.1. Microcatheters
        10.2.2. Guidewires
        10.2.3. Crossing Devices
        10.2.4. Re-entry Devices
        10.2.5. Others
    10.3. Market Value Forecast, by End-user, 2017–2031
        10.3.1. Hospitals
        10.3.2. Ambulatory Surgical Centers
        10.3.3. Others
    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis
        10.5.1. By Product Type
        10.5.2. By End-user
        10.5.3. By Country/Sub-region
11. Asia Pacific Chronic Total Occlusion Devices Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017–2031
        11.2.1. Microcatheters
        11.2.2. Guidewires
        11.2.3. Crossing Devices
        11.2.4. Re-entry Devices
        11.2.5. Others
    11.3. Market Value Forecast, by End-user, 2017–2031
        11.3.1. Hospitals
        11.3.2. Ambulatory Surgical Centers
        11.3.3. Others
    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis
        11.5.1. By Product Type
        11.5.2. By End-user
        11.5.3. By Country/Sub-region
12. Latin America Chronic Total Occlusion Devices Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Microcatheters
        12.2.2. Guidewires
        12.2.3. Crossing Devices
        12.2.4. Re-entry Devices
        12.2.5. Others
    12.3. Market Value Forecast, by End-user, 2017–2031
        12.3.1. Hospitals
        12.3.2. Ambulatory Surgical Centers
        12.3.3. Others
    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis
        12.5.1. By Product Type
        12.5.2. By End-user
        12.5.3. By Country/Sub-region
13. Middle East & Africa Chronic Total Occlusion Devices Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Microcatheters
        13.2.2. Guidewires
        13.2.3. Crossing Devices
        13.2.4. Re-entry Devices
        13.2.5. Others
    13.3. Market Value Forecast, by End-user, 2017–2031
        13.3.1. Hospitals
        13.3.2. Ambulatory Surgical Centers
        13.3.3. Others
    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis
        13.5.1. By Product Type
        13.5.2. By End-user
        13.5.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player - Competition Matrix (by tier and size of companies)
    14.2. Market Share Analysis, by Company, 2022
    14.3. Company Profiles
        14.3.1. Medtronic
            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.1.2. Product Type Portfolio
            14.3.1.3. Financial Overview
            14.3.1.4. SWOT Analysis
            14.3.1.5. Strategic Overview
        14.3.2. Boston Scientific Corporation
            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.2.2. Product Type Portfolio
            14.3.2.3. Financial Overview
            14.3.2.4. SWOT Analysis
            14.3.2.5. Strategic Overview
        14.3.3. Acrostak Int. Distr. Sàrl
            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.3.2. Product Type Portfolio
            14.3.3.3. Financial Overview
            14.3.3.4. SWOT Analysis
            14.3.3.5. Strategic Overview
        14.3.4. Abbott
            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.4.2. Product Type Portfolio
            14.3.4.3. Financial Overview
            14.3.4.4. SWOT Analysis
            14.3.4.5. Strategic Overview
        14.3.5. Asahi Intecc Co., Ltd.
            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.5.2. Product Type Portfolio
            14.3.5.3. Financial Overview
            14.3.5.4. SWOT Analysis
            14.3.5.5. Strategic Overview
        14.3.6. Cardinal Health
            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.6.2. Product Type Portfolio
            14.3.6.3. Financial Overview
            14.3.6.4. SWOT Analysis
            14.3.6.5. Strategic Overview
        14.3.7. Cook Medical
            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.7.2. Product Type Portfolio
            14.3.7.3. Financial Overview
            14.3.7.4. SWOT Analysis
            14.3.7.5. Strategic Overview
        14.3.8. Merit Medical Systems
            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.8.2. Product Type Portfolio
            14.3.8.3. Financial Overview
            14.3.8.4. SWOT Analysis
            14.3.8.5. Strategic Overview
        14.3.9. MicroPort Scientific Corporation
            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.9.2. Product Type Portfolio
            14.3.9.3. Financial Overview
            14.3.9.4. SWOT Analysis
            14.3.9.5. Strategic Overview
        14.3.10. Penumbra, Inc.
            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.10.2. Product Type Portfolio
            14.3.10.3. Financial Overview
            14.3.10.4. SWOT Analysis
            14.3.10.5. Strategic Overview
        14.3.11. Koninklijke Philips N.V.
            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.11.2. Product Type Portfolio
            14.3.11.3. Financial Overview
            14.3.11.4. SWOT Analysis
            14.3.11.5. Strategic Overview
        14.3.12. Terumo India Private Limited
            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.12.2. Product Type Portfolio
            14.3.12.3. Financial Overview
            14.3.12.4. SWOT Analysis
            14.3.12.5. Strategic Overview
        14.3.13. Teleflex Incorporated
            14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.13.2. Product Type Portfolio
            14.3.13.3. Financial Overview
            14.3.13.4. SWOT Analysis
            14.3.13.5. Strategic Overview
        14.3.14. Becton, Dickinson and Company
            14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.14.2. Product Type Portfolio
            14.3.14.3. Financial Overview
            14.3.14.4. SWOT Analysis
            14.3.14.5. Strategic Overview
        14.3.15. Reflow Medical
            14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.15.2. Product Type Portfolio
            14.3.15.3. Financial Overview
            14.3.15.4. SWOT Analysis
            14.3.15.5. Strategic Overview
        14.3.16. Nitiloop
            14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.16.2. Product Type Portfolio
            14.3.16.3. Financial Overview
            14.3.16.4. SWOT Analysis
            14.3.16.5. Strategic Overview

ページTOPに戻る



List of Tables/Graphs

List of Tables

Table 01: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 05: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 08: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 11: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 14: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 17: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 18: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

Transparency Market Research社の医療分野での最新刊レポート


よくあるご質問


Transparency Market Research社はどのような調査会社ですか?


トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る